Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, Hodgkin lymphoma, Lymphoma
Closed
Phase 2
This trial is looking at whether nivolumab can improve treatment before a stem cell transplant for people with Hodgkin lymphoma.
Recruitment start: 3 December 2018
Recruitment end: 11 October 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Graham Collins
Cancer Research UK & UCL Cancer Trials Centre
Bristol-Myers Squibb
University College London
Last reviewed: 17 October 2022
CRUK internal database number: 15560